Mercer Global Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Buy
28,946
+9,729
+51% +$92.9K ﹤0.01% 2919
2026
Q1
$175K Buy
19,217
+5,688
+42% +$47.7K ﹤0.01% 2882
2025
Q4
$101K Buy
13,529
+1,887
+16% +$13.6K ﹤0.01% 2715
2025
Q3
$77.9K Buy
+11,642
New +$80.8K ﹤0.01% 2558

Other funds holding BVS

Mercer Global Advisors's BVS Position: Q2 2026 in Review

Mercer Global Advisors increased its Bioventus (BVS) stake by 51% in Q2 2026, buying an estimated $92.9K and bringing the position to 28,946 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #2919.

Mercer Global Advisors first reported a position in BVS in Q3 2025 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Mercer Global Advisors held 28,946 shares of Bioventus worth $273K as of Q2 2026.
  • Mercer Global Advisors bought 9,729 Bioventus shares in Q2 2026, an estimated $92.9K.
  • Bioventus made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2919 holding.
  • Mercer Global Advisors first reported a position in Bioventus in Q3 2025 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.